BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Duffy SA, Taylor JM, Terrell JE, Islam M, Li Y, Fowler KE, Wolf GT, Teknos TN. Interleukin-6 predicts recurrence and survival among head and neck cancer patients. Cancer. 2008;113:750-757. [PMID: 18536030 DOI: 10.1002/cncr.23615] [Cited by in Crossref: 205] [Cited by in F6Publishing: 189] [Article Influence: 15.8] [Reference Citation Analysis]
Number Citing Articles
1 Hoban CW, Beesley LJ, Bellile EL, Sun Y, Spector ME, Wolf GT, Taylor JMG, Shuman AG. Individualized outcome prognostication for patients with laryngeal cancer. Cancer 2018;124:706-16. [PMID: 29112231 DOI: 10.1002/cncr.31087] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
2 Chen CJ, Sung WW, Lin YM, Chen MK, Lee CH, Lee H, Yeh KT, Ko JL. Gender difference in the prognostic role of interleukin 6 in oral squamous cell carcinoma. PLoS One. 2012;7:e50104. [PMID: 23185547 DOI: 10.1371/journal.pone.0050104] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 2.4] [Reference Citation Analysis]
3 Chaudhary S, Ganguly K, Muniyan S, Pothuraju R, Sayed Z, Jones DT, Batra SK, Macha MA. Immunometabolic Alterations by HPV Infection: New Dimensions to Head and Neck Cancer Disparity. J Natl Cancer Inst 2019;111:233-44. [PMID: 30615137 DOI: 10.1093/jnci/djy207] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 10.0] [Reference Citation Analysis]
4 Visconti L, Nelissen K, Deckx L, van den Akker M, Adriaensen W, Daniels L, Matheï C, Linsen L, Hellings N, Stinissen P. Prognostic value of circulating cytokines on overall survival and disease-free survival in cancer patients. Biomark Med. 2014;8:297-306. [PMID: 24521026 DOI: 10.2217/bmm.13.122] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 2.1] [Reference Citation Analysis]
5 Song L, Wang S, Fang T, Qiu X, Wang X, Zhou X, Morse MA, Hobeika A, Wu W, Yang H, Ren J, Lyerly HK. Changes in Peripheral Blood Regulatory T Cells and IL-6 and IL-10 Levels Predict Response of Pediatric Medulloblastoma and Germ Cell Tumors With Residual or Disseminated Disease to Craniospinal Irradiation. Int J Radiat Oncol Biol Phys 2021;111:479-90. [PMID: 33974888 DOI: 10.1016/j.ijrobp.2021.04.041] [Reference Citation Analysis]
6 Oguro T, Ishibashi K, Sugino T, Hashimoto K, Tomita S, Takahashi N, Yanagida T, Haga N, Aikawa K, Suzutani T, Yamaguchi O, Kojima Y. Humanised antihuman IL-6R antibody with interferon inhibits renal cell carcinoma cell growth in vitro and in vivo through suppressed SOCS3 expression. European Journal of Cancer 2013;49:1715-24. [DOI: 10.1016/j.ejca.2012.11.038] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 3.4] [Reference Citation Analysis]
7 Doescher J, Jeske S, Weissinger SE, Brunner C, Laban S, Bölke E, Hoffmann TK, Whiteside TL, Schuler PJ. Polyfunctionality of CD4+ T lymphocytes is increased after chemoradiotherapy of head and neck squamous cell carcinoma. Strahlenther Onkol 2018;194:392-402. [DOI: 10.1007/s00066-018-1289-z] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
8 Stanam A, Love-Homan L, Joseph TS, Espinosa-Cotton M, Simons AL. Upregulated interleukin-6 expression contributes to erlotinib resistance in head and neck squamous cell carcinoma. Mol Oncol 2015;9:1371-83. [PMID: 25888065 DOI: 10.1016/j.molonc.2015.03.008] [Cited by in Crossref: 27] [Cited by in F6Publishing: 29] [Article Influence: 4.5] [Reference Citation Analysis]
9 Zhou J, Jolly S. Obstructive sleep apnea and fatigue in head and neck cancer patients. Am J Clin Oncol 2015;38:411-4. [PMID: 24762708 DOI: 10.1097/01.coc.0000436086.61460.cb] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 3.5] [Reference Citation Analysis]
10 Shinriki S, Jono H, Ueda M, Ota K, Ota T, Sueyoshi T, Oike Y, Ibusuki M, Hiraki A, Nakayama H, Shinohara M, Ando Y. Interleukin-6 signalling regulates vascular endothelial growth factor-C synthesis and lymphangiogenesis in human oral squamous cell carcinoma. J Pathol 2011;225:142-50. [DOI: 10.1002/path.2935] [Cited by in Crossref: 52] [Cited by in F6Publishing: 46] [Article Influence: 5.2] [Reference Citation Analysis]
11 Moreira J, Tobias A, O'Brien MP, Agulnik M. Targeted Therapy in Head and Neck Cancer: An Update on Current Clinical Developments in Epidermal Growth Factor Receptor-Targeted Therapy and Immunotherapies. Drugs 2017;77:843-57. [PMID: 28382569 DOI: 10.1007/s40265-017-0734-0] [Cited by in Crossref: 28] [Cited by in F6Publishing: 24] [Article Influence: 7.0] [Reference Citation Analysis]
12 Verdonck-de Leeuw IM, Cuijpers P, Leemans CR. Pretreatment depression as a prognostic indicator of survival and nutritional status in patients with head and neck cancer. Cancer 2016;122:971-2. [PMID: 26696404 DOI: 10.1002/cncr.29850] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
13 Saddoughi SA, Garrett-Mayer E, Chaudhary U, O'Brien PE, Afrin LB, Day TA, Gillespie MB, Sharma AK, Wilhoit CS, Bostick R, Senkal CE, Hannun YA, Bielawski J, Simon GR, Shirai K, Ogretmen B. Results of a phase II trial of gemcitabine plus doxorubicin in patients with recurrent head and neck cancers: serum C₁₈-ceramide as a novel biomarker for monitoring response. Clin Cancer Res 2011;17:6097-105. [PMID: 21791630 DOI: 10.1158/1078-0432.CCR-11-0930] [Cited by in Crossref: 47] [Cited by in F6Publishing: 26] [Article Influence: 4.7] [Reference Citation Analysis]
14 Sahu N, Grandis JR. New advances in molecular approaches to head and neck squamous cell carcinoma. Anticancer Drugs 2011;22:656-64. [PMID: 21178766 DOI: 10.1097/CAD.0b013e32834249ba] [Cited by in Crossref: 30] [Cited by in F6Publishing: 19] [Article Influence: 3.0] [Reference Citation Analysis]
15 Prince V, Bellile EL, Sun Y, Wolf GT, Hoban CW, Shuman AG, Taylor JM. Individualized risk prediction of outcomes for oral cavity cancer patients. Oral Oncol 2016;63:66-73. [PMID: 27939002 DOI: 10.1016/j.oraloncology.2016.11.005] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
16 Duffy SA, Ronis DL, McLean S, Fowler KE, Gruber SB, Wolf GT, Terrell JE. Pretreatment health behaviors predict survival among patients with head and neck squamous cell carcinoma. J Clin Oncol 2009;27:1969-75. [PMID: 19289626 DOI: 10.1200/JCO.2008.18.2188] [Cited by in Crossref: 93] [Cited by in F6Publishing: 50] [Article Influence: 7.8] [Reference Citation Analysis]
17 Trivedi S, Concha-Benavente F, Srivastava RM, Jie HB, Gibson SP, Schmitt NC, Ferris RL. Immune biomarkers of anti-EGFR monoclonal antibody therapy. Ann Oncol 2015;26:40-7. [PMID: 24997207 DOI: 10.1093/annonc/mdu156] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 3.4] [Reference Citation Analysis]
18 Sasaki CT, Hajek M, Doukas SG, Vageli DP. The role of bile reflux and its related NF-κB activated pathway in progression of hypopharyngeal squamous cell cancer. Oral Oncol 2020;105:104668. [PMID: 32247988 DOI: 10.1016/j.oraloncology.2020.104668] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
19 LeLaurin JH, Gurka MJ, Chi X, Lee JH, Hall J, Warren GW, Salloum RG. Concordance Between Electronic Health Record and Tumor Registry Documentation of Smoking Status Among Patients With Cancer. JCO Clin Cancer Inform 2021;5:518-26. [PMID: 33974447 DOI: 10.1200/CCI.20.00187] [Reference Citation Analysis]
20 Banerjee R, Van Tubergen EA, Scanlon CS, Vander Broek R, Lints JP, Liu M, Russo N, Inglehart RC, Wang Y, Polverini PJ, Kirkwood KL, D'Silva NJ. The G protein-coupled receptor GALR2 promotes angiogenesis in head and neck cancer. Mol Cancer Ther 2014;13:1323-33. [PMID: 24568968 DOI: 10.1158/1535-7163.MCT-13-0904] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
21 Rudisch A, Dewhurst MR, Horga LG, Kramer N, Harrer N, Dong M, van der Kuip H, Wernitznig A, Bernthaler A, Dolznig H, Sommergruber W. High EMT Signature Score of Invasive Non-Small Cell Lung Cancer (NSCLC) Cells Correlates with NFκB Driven Colony-Stimulating Factor 2 (CSF2/GM-CSF) Secretion by Neighboring Stromal Fibroblasts. PLoS One 2015;10:e0124283. [PMID: 25919140 DOI: 10.1371/journal.pone.0124283] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 4.8] [Reference Citation Analysis]
22 Culig Z. Interleukin-6 as a therapy target in oral squamous carcinoma. Expert Opin Ther Targets 2013;17:53-9. [PMID: 23101455 DOI: 10.1517/14728222.2013.733368] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
23 Chua MM, Ortega CE, Sheikh A, Lee M, Abdul-Rassoul H, Hartshorn KL, Dominguez I. CK2 in Cancer: Cellular and Biochemical Mechanisms and Potential Therapeutic Target. Pharmaceuticals (Basel) 2017;10:E18. [PMID: 28134850 DOI: 10.3390/ph10010018] [Cited by in Crossref: 68] [Cited by in F6Publishing: 48] [Article Influence: 17.0] [Reference Citation Analysis]
24 Klein JD, Sano D, Sen M, Myers JN, Grandis JR, Kim S. STAT3 oligonucleotide inhibits tumor angiogenesis in preclinical models of squamous cell carcinoma. PLoS One 2014;9:e81819. [PMID: 24404126 DOI: 10.1371/journal.pone.0081819] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 2.6] [Reference Citation Analysis]
25 Leibowitz MS, Ferris RL. Recurrence in head and neck squamous cell carcinoma. Editorial. Cancer 2008;113:671-3. [PMID: 18536028 DOI: 10.1002/cncr.23616] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
26 Roi A, Roi CI, Negruțiu ML, Riviș M, Sinescu C, Rusu LC. The Challenges of OSCC Diagnosis: Salivary Cytokines as Potential Biomarkers. J Clin Med 2020;9:E2866. [PMID: 32899735 DOI: 10.3390/jcm9092866] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
27 Shahidi M, Jafari S, Barati M, Mahdipour M, Gholami MS. Predictive value of salivary microRNA-320a, vascular endothelial growth factor receptor 2, CRP and IL-6 in Oral lichen planus progression. Inflammopharmacol 2017;25:577-83. [DOI: 10.1007/s10787-017-0352-1] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
28 Al-Asmari AK, Riyasdeen A, Al-Shahrani MH, Islam M. Snake venom causes apoptosis by increasing the reactive oxygen species in colorectal and breast cancer cell lines. Onco Targets Ther 2016;9:6485-98. [PMID: 27799796 DOI: 10.2147/OTT.S115055] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 2.4] [Reference Citation Analysis]
29 Bernabé DG, Tamae AC, Biasoli ÉR, Oliveira SH. Stress hormones increase cell proliferation and regulates interleukin-6 secretion in human oral squamous cell carcinoma cells. Brain Behav Immun 2011;25:574-83. [PMID: 21187140 DOI: 10.1016/j.bbi.2010.12.012] [Cited by in Crossref: 71] [Cited by in F6Publishing: 68] [Article Influence: 6.5] [Reference Citation Analysis]
30 Johnson DE, O'Keefe RA, Grandis JR. Targeting the IL-6/JAK/STAT3 signalling axis in cancer. Nat Rev Clin Oncol. 2018;15:234-248. [PMID: 29405201 DOI: 10.1038/nrclinonc.2018.8] [Cited by in Crossref: 667] [Cited by in F6Publishing: 614] [Article Influence: 222.3] [Reference Citation Analysis]
31 Sato J, Ohuchi M, Wada M, Ohga N, Asaka T, Yoshikawa K, Miyakoshi M, Hata H, Satoh A, Kitagawa Y. Differences in sequential posttreatment salivary IL-6 levels between patients with and patients without locoregional recurrences of oral squamous cell carcinoma: Part III of a cohort study. Oral Surg Oral Med Oral Pathol Oral Radiol 2015;120:751-60.e2. [PMID: 26548727 DOI: 10.1016/j.oooo.2015.08.016] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
32 Kumar B, Yadav A, Brown NV, Zhao S, Cipolla MJ, Wakely PE, Schmitt AC, Baiocchi RA, Teknos TN, Old M, Kumar P. Nuclear PRMT5, cyclin D1 and IL-6 are associated with poor outcome in oropharyngeal squamous cell carcinoma patients and is inversely associated with p16-status. Oncotarget 2017;8:14847-59. [PMID: 28107179 DOI: 10.18632/oncotarget.14682] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 3.8] [Reference Citation Analysis]
33 Azher S, Azami O, Amato C, McCullough M, Celentano A, Cirillo N. The Non-Conventional Effects of Glucocorticoids in Cancer. J Cell Physiol 2016;231:2368-73. [PMID: 27115293 DOI: 10.1002/jcp.25408] [Cited by in Crossref: 20] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
34 Russo N, Bellile E, Murdoch-Kinch CA, Liu M, Eisbruch A, Wolf GT, D'Silva NJ. Cytokines in saliva increase in head and neck cancer patients after treatment. Oral Surg Oral Med Oral Pathol Oral Radiol 2016;122:483-490.e1. [PMID: 27554375 DOI: 10.1016/j.oooo.2016.05.020] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
35 Verdonck-de Leeuw IM, Jansen F, Brakenhoff RH, Langendijk JA, Takes R, Terhaard CHJ, Baatenburg de Jong RJ, Smit JH, Leemans CR. Advancing interdisciplinary research in head and neck cancer through a multicenter longitudinal prospective cohort study: the NETherlands QUality of life and BIomedical Cohort (NET-QUBIC) data warehouse and biobank. BMC Cancer 2019;19:765. [PMID: 31382921 DOI: 10.1186/s12885-019-5866-z] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 5.5] [Reference Citation Analysis]
36 Yang P, Huang P, Yong L, Chang Y, Wu C, Hua K, Hsieh M, Lee J. Circulating Interleukin-6 is Associated with Prognosis and Genetic Polymorphisms of MIR608 in Patients with Esophageal Squamous Cell Carcinoma. Ann Surg Oncol 2018;25:2449-56. [DOI: 10.1245/s10434-018-6532-4] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
37 Fisman EZ, Tenenbaum A. The ubiquitous interleukin-6: a time for reappraisal. Cardiovasc Diabetol. 2010;9:62. [PMID: 20937099 DOI: 10.1186/1475-2840-9-62] [Cited by in Crossref: 48] [Cited by in F6Publishing: 48] [Article Influence: 4.4] [Reference Citation Analysis]
38 Islam M, Sharma S, Teknos TN. RhoC regulates cancer stem cells in head and neck squamous cell carcinoma by overexpressing IL-6 and phosphorylation of STAT3. PLoS One 2014;9:e88527. [PMID: 24533098 DOI: 10.1371/journal.pone.0088527] [Cited by in Crossref: 35] [Cited by in F6Publishing: 32] [Article Influence: 5.0] [Reference Citation Analysis]
39 LeLaurin JH, Dallery J, Silver NL, Markham MJ, Theis RP, Chetram DK, Staras SA, Gurka MJ, Warren GW, Salloum RG. An Implementation Trial to Improve Tobacco Treatment for Cancer Patients: Patient Preferences, Treatment Acceptability and Effectiveness. Int J Environ Res Public Health 2020;17:E2280. [PMID: 32231062 DOI: 10.3390/ijerph17072280] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
40 Wolf GT, Chepeha DB, Bellile E, Nguyen A, Thomas D, McHugh J; University of Michigan Head and Neck SPORE Program. Tumor infiltrating lymphocytes (TIL) and prognosis in oral cavity squamous carcinoma: a preliminary study. Oral Oncol. 2015;51:90-95. [PMID: 25283344 DOI: 10.1016/j.oraloncology.2014.09.006] [Cited by in Crossref: 87] [Cited by in F6Publishing: 80] [Article Influence: 12.4] [Reference Citation Analysis]
41 Bussu F, Graziani C, Gallus R, Cittadini A, Galli J, DE Corso E, DI Cintio G, Corbi M, Almadori G, Boninsegna A, Paludetti G, Sgambato A. IFN-γ and other serum cytokines in head and neck squamous cell carcinomas. Acta Otorhinolaryngol Ital 2018;38:94-102. [PMID: 29967556 DOI: 10.14639/0392-100X-1530] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
42 Yadav A, Kumar B, Lang JC, Teknos TN, Kumar P. A muscle-specific protein 'myoferlin' modulates IL-6/STAT3 signaling by chaperoning activated STAT3 to nucleus. Oncogene 2017;36:6374-82. [PMID: 28745314 DOI: 10.1038/onc.2017.245] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
43 Zeng YC, Chi F, Xing R, Xue M, Wu LN, Tang MY, Wu R. Pre-treatment neutrophil-to-lymphocyte ratio predicts prognosis in patients with locoregionally advanced laryngeal carcinoma treated with chemoradiotherapy. Jpn J Clin Oncol 2016;46:126-31. [PMID: 26611205 DOI: 10.1093/jjco/hyv175] [Cited by in Crossref: 4] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
44 Crohns M, Saarelainen S, Laine S, Poussa T, Alho H, Kellokumpu-lehtinen P. Cytokines in bronchoalveolar lavage fluid and serum of lung cancer patients during radiotherapy — Association of interleukin-8 and VEGF with survival. Cytokine 2010;50:30-6. [DOI: 10.1016/j.cyto.2009.11.017] [Cited by in Crossref: 43] [Cited by in F6Publishing: 38] [Article Influence: 3.9] [Reference Citation Analysis]
45 Naik PP, Panda PK, Bhutia SK. Oral Cancer Stem Cells Microenvironment. In: Birbrair A, editor. Stem Cell Microenvironments and Beyond. Cham: Springer International Publishing; 2017. pp. 207-33. [DOI: 10.1007/978-3-319-69194-7_11] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
46 Wu JY, Yi C, Chung HR, Wang DJ, Chang WC, Lee SY, Lin CT, Yang YC, Yang WC. Potential biomarkers in saliva for oral squamous cell carcinoma. Oral Oncol 2010;46:226-31. [PMID: 20138569 DOI: 10.1016/j.oraloncology.2010.01.007] [Cited by in Crossref: 106] [Cited by in F6Publishing: 98] [Article Influence: 9.6] [Reference Citation Analysis]
47 Kross KW, Heimdal JH, Aarstad HJ. Mononuclear phagocytes in head and neck squamous cell carcinoma. Eur Arch Otorhinolaryngol 2010;267:335-44. [PMID: 19967383 DOI: 10.1007/s00405-009-1153-y] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
48 Warren GW, Marshall JR, Cummings KM, Zevon MA, Reed R, Hysert P, Mahoney MC, Hyland AJ, Nwogu C, Demmy T, Dexter E, Kelly M, O'Connor RJ, Houstin T, Jenkins D, Germain P, Singh AK, Epstein J, Dobson Amato KA, Reid ME. Automated tobacco assessment and cessation support for cancer patients. Cancer 2014;120:562-9. [PMID: 24496870 DOI: 10.1002/cncr.28440] [Cited by in Crossref: 51] [Cited by in F6Publishing: 37] [Article Influence: 6.4] [Reference Citation Analysis]
49 Jing Z, Xu H, Chen X, Zhong Q, Huang J, Zhang Y, Guo W, Yang Z, Ding S, Chen P, Huang Z. The Proton-Sensing G-Protein Coupled Receptor GPR4 Promotes Angiogenesis in Head and Neck Cancer. PLoS One 2016;11:e0152789. [PMID: 27078157 DOI: 10.1371/journal.pone.0152789] [Cited by in Crossref: 30] [Cited by in F6Publishing: 25] [Article Influence: 6.0] [Reference Citation Analysis]
50 Sannam Khan R, Khurshid Z, Akhbar S, Faraz Moin S. Advances of Salivary Proteomics in Oral Squamous Cell Carcinoma (OSCC) Detection: An Update. Proteomes 2016;4:E41. [PMID: 28248250 DOI: 10.3390/proteomes4040041] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 4.6] [Reference Citation Analysis]
51 Jimi E, Furuta H, Matsuo K, Tominaga K, Takahashi T, Nakanishi O. The cellular and molecular mechanisms of bone invasion by oral squamous cell carcinoma: Mechanisms of bone invasion. Oral Diseases 2011;17:462-8. [DOI: 10.1111/j.1601-0825.2010.01781.x] [Cited by in Crossref: 59] [Cited by in F6Publishing: 45] [Article Influence: 5.4] [Reference Citation Analysis]
52 Gallo O. Risk for COVID-19 infection in patients with tobacco smoke-associated cancers of the upper and lower airway. Eur Arch Otorhinolaryngol 2021;278:2695-702. [PMID: 33216184 DOI: 10.1007/s00405-020-06456-z] [Reference Citation Analysis]
53 Mojtahedi Z, Khademi B, Hashemi SB, Abtahi SM, Ghasemi MA, Fattahi MJ, Ghaderi A. Serum interleukine-6 concentration, but not interleukine-18, is associated with head and neck squamous cell carcinoma progression. Pathol Oncol Res 2011;17:7-10. [PMID: 20340055 DOI: 10.1007/s12253-010-9261-y] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 1.7] [Reference Citation Analysis]
54 Singh P, Verma JK, Singh JK. Validation of Salivary Markers, IL-1β, IL-8 and Lgals3bp for Detection of Oral Squamous Cell Carcinoma in an Indian Population. Sci Rep 2020;10:7365. [PMID: 32355279 DOI: 10.1038/s41598-020-64494-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
55 Naik PP, Das DN, Panda PK, Mukhopadhyay S, Sinha N, Praharaj PP, Agarwal R, Bhutia SK. Implications of cancer stem cells in developing therapeutic resistance in oral cancer. Oral Oncol 2016;62:122-35. [PMID: 27865365 DOI: 10.1016/j.oraloncology.2016.10.008] [Cited by in Crossref: 41] [Cited by in F6Publishing: 31] [Article Influence: 8.2] [Reference Citation Analysis]
56 Mishra AK, Kemler I, Dingli D. Preclinical development of CD126 CAR-T cells with broad antitumor activity. Blood Cancer J 2021;11:3. [PMID: 33414408 DOI: 10.1038/s41408-020-00405-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
57 Fang KH, Lai CH, Hsu CM, Huang E, Tsai MS, Chang GH, Lee YC, Tsai YT. A retrospective study on the prognostic value of preoperative C-reactive protein to albumin ratio in patients with oral cavity squamous cell carcinoma. PeerJ 2020;8:e9361. [PMID: 32587804 DOI: 10.7717/peerj.9361] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
58 Skrinjar I, Brailo V, Vidovic-Juras D, Vucicevic-Boras V, Milenovic A. Evaluation of pretreatment serum interleukin-6 and tumour necrosis factor alpha as a potential biomarker for recurrence in patients with oral squamous cell carcinoma. Med Oral Patol Oral Cir Bucal 2015;20:e402-7. [PMID: 25858079 DOI: 10.4317/medoral.20373] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 2.7] [Reference Citation Analysis]
59 Vistad I, Skorstad M, Demmelmaier I, Småstuen MC, Lindemann K, Wisløff T, van de Poll-Franse LV, Berntsen S. Lifestyle and Empowerment Techniques in Survivorship of Gynaecologic Oncology (LETSGO study): a study protocol for a multicentre longitudinal interventional study using mobile health technology and biobanking. BMJ Open 2021;11:e050930. [PMID: 34253678 DOI: 10.1136/bmjopen-2021-050930] [Reference Citation Analysis]
60 Neiva KG, Zhang Z, Miyazawa M, Warner KA, Karl E, Nör JE. Cross talk initiated by endothelial cells enhances migration and inhibits anoikis of squamous cell carcinoma cells through STAT3/Akt/ERK signaling. Neoplasia 2009;11:583-93. [PMID: 19484147 DOI: 10.1593/neo.09266] [Cited by in Crossref: 105] [Cited by in F6Publishing: 90] [Article Influence: 8.8] [Reference Citation Analysis]
61 Shinagawa K, Yanamoto S, Naruse T, Kawakita A, Morishita K, Sakamoto Y, Rokutanda S, Umeda M. Clinical Roles of Interleukin-6 and STAT3 in Oral Squamous Cell Carcinoma. Pathol Oncol Res 2017;23:425-31. [PMID: 27744625 DOI: 10.1007/s12253-016-0134-x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
62 Van Tubergen E, Vander Broek R, Lee J, Wolf G, Carey T, Bradford C, Prince M, Kirkwood KL, D'Silva NJ. Tristetraprolin regulates interleukin-6, which is correlated with tumor progression in patients with head and neck squamous cell carcinoma. Cancer 2011;117:2677-89. [PMID: 21656745 DOI: 10.1002/cncr.25859] [Cited by in Crossref: 43] [Cited by in F6Publishing: 48] [Article Influence: 4.3] [Reference Citation Analysis]
63 Iyengar NM, Ghossein RA, Morris LG, Zhou XK, Kochhar A, Morris PG, Pfister DG, Patel SG, Boyle JO, Hudis CA, Dannenberg AJ. White adipose tissue inflammation and cancer-specific survival in patients with squamous cell carcinoma of the oral tongue. Cancer 2016;122:3794-802. [PMID: 27508351 DOI: 10.1002/cncr.30251] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 5.2] [Reference Citation Analysis]
64 Wu D, Cheng J, Sun G, Wu S, Li M, Gao Z, Zhai S, Li P, Su D, Wang X. p70S6K promotes IL-6-induced epithelial-mesenchymal transition and metastasis of head and neck squamous cell carcinoma. Oncotarget 2016;7:36539-50. [PMID: 27174914 DOI: 10.18632/oncotarget.9282] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 6.8] [Reference Citation Analysis]
65 Meirovitz A, Kuten M, Billan S, Abdah-Bortnyak R, Sharon A, Peretz T, Sela M, Schaffer M, Barak V. Cytokines levels, severity of acute mucositis and the need of PEG tube installation during chemo-radiation for head and neck cancer--a prospective pilot study. Radiat Oncol 2010;5:16. [PMID: 20184737 DOI: 10.1186/1748-717X-5-16] [Cited by in Crossref: 49] [Cited by in F6Publishing: 20] [Article Influence: 4.5] [Reference Citation Analysis]
66 Yang CY, Lin CK, Lin GJ, Hsieh CC, Huang SH, Ma KH, Shieh YS, Sytwu HK, Chen YW. Triptolide represses oral cancer cell proliferation, invasion, migration, and angiogenesis in co-inoculation with U937 cells. Clin Oral Investig 2017;21:419-27. [PMID: 27073100 DOI: 10.1007/s00784-016-1808-1] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
67 Mochizuki D, Adams A, Warner KA, Zhang Z, Pearson AT, Misawa K, McLean SA, Wolf GT, Nör JE. Anti-tumor effect of inhibition of IL-6 signaling in mucoepidermoid carcinoma. Oncotarget 2015;6:22822-35. [PMID: 26287605 DOI: 10.18632/oncotarget.4477] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 4.2] [Reference Citation Analysis]
68 Beesley LJ, Shuman AG, Mierzwa ML, Bellile EL, Rosen BS, Casper KA, Ibrahim M, Dermody SM, Wolf GT, Chinn SB, Spector ME, Baatenburg de Jong RJ, Dronkers EAC, Taylor JMG. Development and Assessment of a Model for Predicting Individualized Outcomes in Patients With Oropharyngeal Cancer. JAMA Netw Open 2021;4:e2120055. [PMID: 34369988 DOI: 10.1001/jamanetworkopen.2021.20055] [Reference Citation Analysis]
69 Polanska H, Raudenska M, Gumulec J, Sztalmachova M, Adam V, Kizek R, Masarik M. Clinical significance of head and neck squamous cell cancer biomarkers. Oral Oncology 2014;50:168-77. [DOI: 10.1016/j.oraloncology.2013.12.008] [Cited by in Crossref: 63] [Cited by in F6Publishing: 53] [Article Influence: 9.0] [Reference Citation Analysis]
70 Yan B, Wei J, Yuan Y, Sun R, Li D, Luo J, Liao S, Zhou Y, Shu Y, Wang Q, Zhang G, Feng Z. IL-6 Cooperates with G-CSF To Induce Protumor Function of Neutrophils in Bone Marrow by Enhancing STAT3 Activation. J I 2013;190:5882-93. [DOI: 10.4049/jimmunol.1201881] [Cited by in Crossref: 61] [Cited by in F6Publishing: 54] [Article Influence: 7.6] [Reference Citation Analysis]
71 Johnston PA, Sen M, Hua Y, Camarco DP, Shun TY, Lazo JS, Wilson GM, Resnick LO, LaPorte MG, Wipf P, Huryn DM, Grandis JR. HCS campaign to identify selective inhibitors of IL-6-induced STAT3 pathway activation in head and neck cancer cell lines. Assay Drug Dev Technol 2015;13:356-76. [PMID: 26317883 DOI: 10.1089/adt.2015.663] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 3.8] [Reference Citation Analysis]
72 Islam M, Sharma S, Kumar B, Teknos TN. Atorvastatin inhibits RhoC function and limits head and neck cancer metastasis. Oral Oncol 2013;49:778-86. [PMID: 23648017 DOI: 10.1016/j.oraloncology.2013.04.003] [Cited by in Crossref: 34] [Cited by in F6Publishing: 30] [Article Influence: 4.3] [Reference Citation Analysis]
73 Mallery SR, Wang D, Santiago B, Pei P, Bissonnette C, Jayawardena JA, Schwendeman SP, Spinney R, Lang J. Fenretinide, Tocilizumab, and Reparixin Provide Multifaceted Disruption of Oral Squamous Cell Carcinoma Stem Cell Properties: Implications for Tertiary Chemoprevention. Mol Cancer Ther 2019;18:2308-20. [PMID: 31515297 DOI: 10.1158/1535-7163.MCT-19-0361] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
74 Shkeir O, Athanassiou-Papaefthymiou M, Lapadatescu M, Papagerakis P, Czerwinski MJ, Bradford CR, Carey TE, Prince ME, Wolf GT, Papagerakis S. In vitro cytokine release profile: predictive value for metastatic potential in head and neck squamous cell carcinomas. Head Neck 2013;35:1542-50. [PMID: 23322448 DOI: 10.1002/hed.23191] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
75 Huang Y, Yang H, Hsu Y, Chiu P, Ou G, Hsu M. Src contributes to IL6-induced vascular endothelial growth factor-C expression in lymphatic endothelial cells. Angiogenesis 2014;17:407-18. [DOI: 10.1007/s10456-013-9386-1] [Cited by in Crossref: 26] [Cited by in F6Publishing: 20] [Article Influence: 3.3] [Reference Citation Analysis]
76 Mojtahedi Z, Khademi B, Yehya A, Talebi A, Fattahi MJ, Ghaderi A. Serum levels of interleukins 4 and 10 in head and neck squamous cell carcinoma. J Laryngol Otol 2012;126:175-9. [PMID: 21888745 DOI: 10.1017/S0022215111002349] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
77 Yadav A, Kumar B, Datta J, Teknos TN, Kumar P. IL-6 promotes head and neck tumor metastasis by inducing epithelial-mesenchymal transition via the JAK-STAT3-SNAIL signaling pathway. Mol Cancer Res 2011;9:1658-67. [PMID: 21976712 DOI: 10.1158/1541-7786.MCR-11-0271] [Cited by in Crossref: 292] [Cited by in F6Publishing: 175] [Article Influence: 29.2] [Reference Citation Analysis]
78 Wong TH, Skanthakumar T, Nadkarni N, Nguyen HV, Iyer NG. Survival of patients with head and neck squamous cell carcinoma by housing subsidy in a tiered public housing system. Cancer 2017;123:1998-2005. [PMID: 28135397 DOI: 10.1002/cncr.30557] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
79 Zhang L, Liu W, Gao Y, Qin Y, Wu R. The expression of IL-6 and STAT3 might predict progression and unfavorable prognosis in Wilms’ tumor. Biochemical and Biophysical Research Communications 2013;435:408-13. [DOI: 10.1016/j.bbrc.2013.04.102] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
80 Bagan L, Sáez GT, Tormos MC, Labaig-rueda C, Murillo-cortes J, Bagan JV. Salivary and serum interleukin-6 levels in proliferative verrucous leukoplakia. Clin Oral Invest 2016;20:737-43. [DOI: 10.1007/s00784-015-1551-z] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
81 Punt S, Corver WE, van der Zeeuw SA, Kielbasa SM, Osse EM, Buermans HP, de Kroon CD, Jordanova ES, Gorter A. Whole-transcriptome analysis of flow-sorted cervical cancer samples reveals that B cell expressed TCL1A is correlated with improved survival. Oncotarget 2015;6:38681-94. [PMID: 26299617 DOI: 10.18632/oncotarget.4526] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
82 Zeng YC, Xue M, Chi F, Xu ZG, Fan GL, Wu R, Fan YC, Zhong WZ, Wang SL, Zhang XY, Wu LN, Chen XD, Jin XY, Duan QY, Xu R, Chen W, Qian HC, Xiao YP. C-reactive protein level predicts prognosis in patients with locoregionally advanced laryngeal carcinoma treated with chemoradiotherapy. Tumour Biol 2012;33:891-5. [PMID: 22311704 DOI: 10.1007/s13277-012-0330-6] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
83 DiNatale BC, Schroeder JC, Perdew GH. Ah receptor antagonism inhibits constitutive and cytokine inducible IL6 production in head and neck tumor cell lines. Mol Carcinog 2011;50:173-83. [PMID: 21104991 DOI: 10.1002/mc.20702] [Cited by in Crossref: 42] [Cited by in F6Publishing: 41] [Article Influence: 3.8] [Reference Citation Analysis]
84 Uz U, Eskiizmir G. Association Between Interleukin-6 and Head and Neck Squamous Cell Carcinoma: A Systematic Review. Clin Exp Otorhinolaryngol 2021;14:50-60. [PMID: 33587847 DOI: 10.21053/ceo.2019.00906] [Reference Citation Analysis]
85 Hanna GJ, Liu H, Jones RE, Bacay AF, Lizotte PH, Ivanova EV, Bittinger MA, Cavanaugh ME, Rode AJ, Schoenfeld JD, Chau NG, Haddad RI, Lorch JH, Wong KK, Uppaluri R, Hammerman PS. Defining an inflamed tumor immunophenotype in recurrent, metastatic squamous cell carcinoma of the head and neck. Oral Oncol 2017;67:61-9. [PMID: 28351582 DOI: 10.1016/j.oraloncology.2017.02.005] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 7.3] [Reference Citation Analysis]
86 Yu ST, Zhou Z, Cai Q, Liang F, Han P, Chen R, Huang XM. Prognostic value of the C-reactive protein/albumin ratio in patients with laryngeal squamous cell carcinoma. Onco Targets Ther 2017;10:879-84. [PMID: 28243123 DOI: 10.2147/OTT.S128391] [Cited by in Crossref: 16] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
87 Fialová A, Koucký V, Hajdušková M, Hladíková K, Špíšek R. Immunological Network in Head and Neck Squamous Cell Carcinoma-A Prognostic Tool Beyond HPV Status. Front Oncol 2020;10:1701. [PMID: 33042814 DOI: 10.3389/fonc.2020.01701] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
88 Yutani S, Komatsu N, Matsueda S, Yoshitomi M, Shirahama T, Yamada A, Itoh K, Sasada T. Juzentaihoto Failed to Augment Antigen-Specific Immunity but Prevented Deterioration of Patients' Conditions in Advanced Pancreatic Cancer under Personalized Peptide Vaccine. Evid Based Complement Alternat Med 2013;2013:981717. [PMID: 23840274 DOI: 10.1155/2013/981717] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
89 Economopoulou P, Kotsantis I, Psyrri A. Tumor Microenvironment and Immunotherapy Response in Head and Neck Cancer. Cancers (Basel) 2020;12:E3377. [PMID: 33203092 DOI: 10.3390/cancers12113377] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
90 Khurshid Z, Zafar MS, Khan RS, Najeeb S, Slowey PD, Rehman IU. Role of Salivary Biomarkers in Oral Cancer Detection. Adv Clin Chem 2018;86:23-70. [PMID: 30144841 DOI: 10.1016/bs.acc.2018.05.002] [Cited by in Crossref: 65] [Cited by in F6Publishing: 46] [Article Influence: 21.7] [Reference Citation Analysis]
91 Qian X, Ma C, Nie X, Lu J, Lenarz M, Kaufmann AM, Albers AE. Biology and immunology of cancer stem(-like) cells in head and neck cancer. Critical Reviews in Oncology/Hematology 2015;95:337-45. [DOI: 10.1016/j.critrevonc.2015.03.009] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 4.7] [Reference Citation Analysis]
92 Koukourakis MI, Kambouromiti G, Pitsiava D, Tsousou P, Tsiarkatsi M, Kartalis G. Serum C-reactive protein (CRP) levels in cancer patients are linked with tumor burden and are reduced by anti-hypertensive medication. Inflammation 2009;32:169-75. [PMID: 19373547 DOI: 10.1007/s10753-009-9116-4] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 1.9] [Reference Citation Analysis]
93 Arthur AE, Peterson KE, Rozek LS, Taylor JM, Light E, Chepeha DB, Hébert JR, Terrell JE, Wolf GT, Duffy SA; UM Head and Neck SPORE Program. Pretreatment dietary patterns, weight status, and head and neck squamous cell carcinoma prognosis. Am J Clin Nutr 2013;97:360-8. [PMID: 23269814 DOI: 10.3945/ajcn.112.044859] [Cited by in Crossref: 40] [Cited by in F6Publishing: 33] [Article Influence: 4.4] [Reference Citation Analysis]
94 Whiteside TL. Head and Neck Carcinoma Immunotherapy: Facts and Hopes. Clin Cancer Res 2018;24:6-13. [PMID: 28751445 DOI: 10.1158/1078-0432.CCR-17-1261] [Cited by in Crossref: 38] [Cited by in F6Publishing: 29] [Article Influence: 9.5] [Reference Citation Analysis]
95 Kaczor-urbanowicz KE, Wong DT. Proteomics. Translational Systems Medicine and Oral Disease. Elsevier; 2020. pp. 93-118. [DOI: 10.1016/b978-0-12-813762-8.00004-9] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
96 Gasche JA, Hoffmann J, Boland CR, Goel A. Interleukin-6 promotes tumorigenesis by altering DNA methylation in oral cancer cells. Int J Cancer 2011;129:1053-63. [PMID: 21710491 DOI: 10.1002/ijc.25764] [Cited by in Crossref: 101] [Cited by in F6Publishing: 95] [Article Influence: 10.1] [Reference Citation Analysis]
97 Muraro E, Fanetti G, Lupato V, Giacomarra V, Steffan A, Gobitti C, Vaccher E, Franchin G. Cetuximab in locally advanced head and neck squamous cell carcinoma: Biological mechanisms involved in efficacy, toxicity and resistance. Crit Rev Oncol Hematol 2021;164:103424. [PMID: 34245856 DOI: 10.1016/j.critrevonc.2021.103424] [Reference Citation Analysis]
98 Beesley LJ, Hawkins PG, Amlani LM, Bellile EL, Casper KA, Chinn SB, Eisbruch A, Mierzwa ML, Spector ME, Wolf GT, Shuman AG, Taylor JMG. Individualized survival prediction for patients with oropharyngeal cancer in the human papillomavirus era. Cancer 2019;125:68-78. [PMID: 30291798 DOI: 10.1002/cncr.31739] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.7] [Reference Citation Analysis]
99 Ekblad L, Lindgren G, Persson E, Kjellén E, Wennerberg J. Cell-line-specific stimulation of tumor cell aggressiveness by wound healing factors - a central role for STAT3. BMC Cancer. 2013;13:33. [PMID: 23351302 DOI: 10.1186/1471-2407-13-33] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
100 Czerninski R, Basile J, Kartin‐gabay T, Laviv A, Barak V. Cytokines and tumor markers in potentially malignant disorders and oral squamous cell carcinoma: a pilot study. Oral Dis 2014;20:477-81. [DOI: 10.1111/odi.12160] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.5] [Reference Citation Analysis]
101 O'Keefe RA, Bhola NE, Lee DS, Johnson DE, Grandis JR. Interleukin 6 is increased in preclinical HNSCC models of acquired cetuximab resistance, but is not required for maintenance of resistance. PLoS One 2020;15:e0227261. [PMID: 31914141 DOI: 10.1371/journal.pone.0227261] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
102 Krishnamurthy S, Warner KA, Dong Z, Imai A, Nör C, Ward BB, Helman JI, Taichman RS, Bellile EL, McCauley LK, Polverini PJ, Prince ME, Wicha MS, Nör JE. Endothelial interleukin-6 defines the tumorigenic potential of primary human cancer stem cells. Stem Cells 2014;32:2845-57. [PMID: 25078284 DOI: 10.1002/stem.1793] [Cited by in Crossref: 60] [Cited by in F6Publishing: 50] [Article Influence: 10.0] [Reference Citation Analysis]
103 Chen CC, Chen WC, Lu CH, Wang WH, Lin PY, Lee KD, Chen MF. Significance of interleukin-6 signaling in the resistance of pharyngeal cancer to irradiation and the epidermal growth factor receptor inhibitor. Int J Radiat Oncol Biol Phys 2010;76:1214-24. [PMID: 20206020 DOI: 10.1016/j.ijrobp.2009.09.059] [Cited by in Crossref: 41] [Cited by in F6Publishing: 37] [Article Influence: 3.7] [Reference Citation Analysis]
104 Fletcher EV, Love-Homan L, Sobhakumari A, Feddersen CR, Koch AT, Goel A, Simons AL. EGFR inhibition induces proinflammatory cytokines via NOX4 in HNSCC. Mol Cancer Res 2013;11:1574-84. [PMID: 24048704 DOI: 10.1158/1541-7786.MCR-13-0187] [Cited by in Crossref: 35] [Cited by in F6Publishing: 28] [Article Influence: 4.4] [Reference Citation Analysis]
105 Bruchhage KL, Heinrichs S, Wollenberg B, Pries R. IL-10 in the microenvironment of HNSCC inhibits the CpG ODN induced IFN-α secretion of pDCs. Oncol Lett 2018;15:3985-90. [PMID: 29456743 DOI: 10.3892/ol.2018.7772] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
106 Allen CT, Judd NP, Bui JD, Uppaluri R. The clinical implications of antitumor immunity in head and neck cancer. The Laryngoscope 2012;122:144-57. [DOI: 10.1002/lary.21913] [Cited by in Crossref: 37] [Cited by in F6Publishing: 33] [Article Influence: 3.7] [Reference Citation Analysis]
107 Chen CC, Chen WC, Wang WH, Lu CH, Lin PY, Lee KD, Chen MF. Role of DNA methyltransferase 1 in pharyngeal cancer related to treatment resistance. Head Neck 2011;33:1132-43. [PMID: 21284050 DOI: 10.1002/hed.21586] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
108 Choudhary MM, France TJ, Teknos TN, Kumar P. Interleukin-6 role in head and neck squamous cell carcinoma progression. World J Otorhinolaryngol Head Neck Surg 2016;2:90-7. [PMID: 29204553 DOI: 10.1016/j.wjorl.2016.05.002] [Cited by in Crossref: 31] [Cited by in F6Publishing: 26] [Article Influence: 6.2] [Reference Citation Analysis]
109 Baral R, Bose A, Ray C, Paul S, Pal S, Haque E, Mishra B, Pal D, Nagpal JK, Panda CK, Das BR. Association of early phase of colorectal carcinogenesis with STAT3 activation and its relevance in apoptosis regulation. Experimental and Molecular Pathology 2009;87:36-41. [DOI: 10.1016/j.yexmp.2009.03.002] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
110 Aarstad HH, Vintermyr OK, Ulvestad E, Kross K, Heimdal JH, Aarstad HJ. In Vitro-Stimulated IL-6 Monocyte Secretion and In Vivo Peripheral Blood T Lymphocyte Activation Uniquely Predicted 15-Year Survival in Patients with Head and Neck Squamous Cell Carcinoma. PLoS One 2015;10:e0129724. [PMID: 26079381 DOI: 10.1371/journal.pone.0129724] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
111 Beesley LJ, Taylor JMG. EM algorithms for fitting multistate cure models. Biostatistics 2019;20:416-32. [PMID: 29584820 DOI: 10.1093/biostatistics/kxy011] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
112 Nguyen TTH, Sodnom-Ish B, Choi SW, Jung HI, Cho J, Hwang I, Kim SM. Salivary biomarkers in oral squamous cell carcinoma. J Korean Assoc Oral Maxillofac Surg 2020;46:301-12. [PMID: 33122454 DOI: 10.5125/jkaoms.2020.46.5.301] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
113 Beesley LJ, Bartlett JW, Wolf GT, Taylor JM. Multiple imputation of missing covariates for the Cox proportional hazards cure model. Stat Med 2016;35:4701-17. [PMID: 27439726 DOI: 10.1002/sim.7048] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
114 Wang F, Arun P, Friedman J, Chen Z, Van Waes C. Current and potential inflammation targeted therapies in head and neck cancer. Curr Opin Pharmacol 2009;9:389-95. [PMID: 19570715 DOI: 10.1016/j.coph.2009.06.005] [Cited by in Crossref: 54] [Cited by in F6Publishing: 50] [Article Influence: 4.5] [Reference Citation Analysis]
115 Nakahira M, Sugasawa M, Matsumura S, Kuba K, Ohba S, Hayashi T, Minami K, Ebihara Y, Kogashiwa Y. Prognostic role of the combination of platelet count and neutrophil-lymphocyte ratio in patients with hypopharyngeal squamous cell carcinoma. Eur Arch Otorhinolaryngol 2016;273:3863-7. [PMID: 27020267 DOI: 10.1007/s00405-016-3996-3] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 4.4] [Reference Citation Analysis]
116 Shin DY, Jang KS, Kim BY, Choi JE, Yoon H, Ko YH, Jeong HS. Comparison of adenoid cystic carcinomas arising from the parotid gland vs. the submandibular gland: focus on systemic metastasis and tumor-associated blood vessels. J Oral Pathol Med 2014;43:441-7. [PMID: 24456477 DOI: 10.1111/jop.12155] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
117 Kany S, Vollrath JT, Relja B. Cytokines in Inflammatory Disease. Int J Mol Sci. 2019;20. [PMID: 31795299 DOI: 10.3390/ijms20236008] [Cited by in Crossref: 231] [Cited by in F6Publishing: 157] [Article Influence: 115.5] [Reference Citation Analysis]
118 Choi SH, Terrell JE, Fowler KE, McLean SA, Ghanem T, Wolf GT, Bradford CR, Taylor J, Duffy SA. Socioeconomic and Other Demographic Disparities Predicting Survival among Head and Neck Cancer Patients. PLoS One 2016;11:e0149886. [PMID: 26930647 DOI: 10.1371/journal.pone.0149886] [Cited by in Crossref: 56] [Cited by in F6Publishing: 51] [Article Influence: 11.2] [Reference Citation Analysis]
119 Braakhuis BJ, Graveland AP, Dijk F, Ylstra B, van Wieringen WN, Leemans CR, Brakenhoff RH. Expression signature in peripheral blood cells for molecular diagnosis of head and neck squamous cell carcinoma. Oral Dis 2013;19:452-5. [PMID: 23034102 DOI: 10.1111/odi.12019] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
120 Nör C, Zhang Z, Warner KA, Bernardi L, Visioli F, Helman JI, Roesler R, Nör JE. Cisplatin induces Bmi-1 and enhances the stem cell fraction in head and neck cancer. Neoplasia. 2014;16:137-146. [PMID: 24709421 DOI: 10.1593/neo.131744] [Cited by in Crossref: 87] [Cited by in F6Publishing: 86] [Article Influence: 12.4] [Reference Citation Analysis]
121 Jinno T, Kawano S, Maruse Y, Matsubara R, Goto Y, Sakamoto T, Hashiguchi Y, Kaneko N, Tanaka H, Kitamura R, Toyoshima T, Jinno A, Moriyama M, Oobu K, Kiyoshima T, Nakamura S. Increased expression of interleukin-6 predicts poor response to chemoradiotherapy and unfavorable prognosis in oral squamous cell carcinoma. Oncol Rep 2015;33:2161-8. [PMID: 25761055 DOI: 10.3892/or.2015.3838] [Cited by in Crossref: 51] [Cited by in F6Publishing: 49] [Article Influence: 8.5] [Reference Citation Analysis]
122 Hess J, Unger K, Orth M, Schötz U, Schüttrumpf L, Zangen V, Gimenez-Aznar I, Michna A, Schneider L, Stamp R, Selmansberger M, Braselmann H, Hieber L, Drexler GA, Kuger S, Klein D, Jendrossek V, Friedl AA, Belka C, Zitzelsberger H, Lauber K. Genomic amplification of Fanconi anemia complementation group A (FancA) in head and neck squamous cell carcinoma (HNSCC): Cellular mechanisms of radioresistance and clinical relevance. Cancer Lett 2017;386:87-99. [PMID: 27867017 DOI: 10.1016/j.canlet.2016.11.014] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 2.4] [Reference Citation Analysis]
123 Gao J, Zhao S, Halstensen TS. Increased interleukin-6 expression is associated with poor prognosis and acquired cisplatin resistance in head and neck squamous cell carcinoma. Oncol Rep 2016;35:3265-74. [PMID: 27108527 DOI: 10.3892/or.2016.4765] [Cited by in Crossref: 41] [Cited by in F6Publishing: 35] [Article Influence: 8.2] [Reference Citation Analysis]
124 Veigas F, Mahmoud YD, Merlo J, Rinflerch A, Rabinovich GA, Girotti MR. Immune Checkpoints Pathways in Head and Neck Squamous Cell Carcinoma. Cancers (Basel) 2021;13:1018. [PMID: 33804419 DOI: 10.3390/cancers13051018] [Reference Citation Analysis]
125 Yan B, Broek RV, Saleh AD, Mehta A, Van Waes C, Chen Z. Signaling Networks of Activated Oncogenic and Altered Tumor Suppressor Genes in Head and Neck Cancer. J Carcinog Mutagen 2013;Suppl 7:4. [PMID: 25587491 DOI: 10.4172/2157-2518.S7-004] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
126 Yadav A, Kumar B, Teknos TN, Kumar P. Bazedoxifene enhances the anti-tumor effects of cisplatin and radiation treatment by blocking IL-6 signaling in head and neck cancer. Oncotarget 2017;8:66912-24. [PMID: 28978005 DOI: 10.18632/oncotarget.11464] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
127 Hagi T, Nakamura T, Iino T, Matsubara T, Asanuma K, Matsumine A, Sudo A. The diagnostic and prognostic value of interleukin-6 in patients with soft tissue sarcomas. Sci Rep 2017;7:9640. [PMID: 28851899 DOI: 10.1038/s41598-017-08781-6] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
128 Stone SC, Rossetti RA, Lima AM, Lepique AP. HPV associated tumor cells control tumor microenvironment and leukocytosis in experimental models. Immun Inflamm Dis 2014;2:63-75. [PMID: 25400927 DOI: 10.1002/iid3.21] [Cited by in Crossref: 31] [Cited by in F6Publishing: 30] [Article Influence: 4.4] [Reference Citation Analysis]
129 Travassos DC, Fernandes D, Massucato EMS, Navarro CM, Bufalino A. Squamous cell carcinoma antigen as a prognostic marker and its correlation with clinicopathological features in head and neck squamous cell carcinoma: Systematic review and meta-analysis. J Oral Pathol Med 2018;47:3-10. [DOI: 10.1111/jop.12600] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
130 Bello IO, Soini Y, Salo T. Prognostic evaluation of oral tongue cancer: Means, markers and perspectives (I). Oral Oncology 2010;46:630-5. [DOI: 10.1016/j.oraloncology.2010.06.006] [Cited by in Crossref: 98] [Cited by in F6Publishing: 88] [Article Influence: 8.9] [Reference Citation Analysis]
131 Aarstad HH, Moe SEE, Bruserud Ø, Lybak S, Aarstad HJ, Tvedt THA. The Acute Phase Reaction and Its Prognostic Impact in Patients with Head and Neck Squamous Cell Carcinoma: Single Biomarkers Including C-Reactive Protein Versus Biomarker Profiles. Biomedicines 2020;8:E418. [PMID: 33066437 DOI: 10.3390/biomedicines8100418] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
132 Finkel KA, Warner KA, Kerk S, Bradford CR, McLean SA, Prince ME, Zhong H, Hurt EM, Hollingsworth RE, Wicha MS, Tice DA, Nör JE. IL-6 Inhibition With MEDI5117 Decreases The Fraction of Head and Neck Cancer Stem Cells and Prevents Tumor Recurrence. Neoplasia 2016;18:273-81. [PMID: 27237319 DOI: 10.1016/j.neo.2016.03.004] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 3.2] [Reference Citation Analysis]
133 Shah FD, Begum R, Vajaria BN, Patel KR, Patel JB, Shukla SN, Patel PS. A review on salivary genomics and proteomics biomarkers in oral cancer. Indian J Clin Biochem 2011;26:326-34. [PMID: 23024467 DOI: 10.1007/s12291-011-0149-8] [Cited by in Crossref: 64] [Cited by in F6Publishing: 50] [Article Influence: 6.4] [Reference Citation Analysis]
134 Cha H, Lee EJ, Seong J. Multi-analyte analysis of cytokines that predict outcomes in patients with hepatocellular carcinoma treated with radiotherapy. World J Gastroenterol 2017;23:2077-85. [PMID: 28373775 DOI: 10.3748/wjg.v23.i11.2077] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
135 Duffy SA, Teknos T, Taylor JM, Fowler KE, Islam M, Wolf GT, McLean S, Ghanem TA, Terrell JE. Health behaviors predict higher interleukin-6 levels among patients newly diagnosed with head and neck squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev 2013;22:374-81. [PMID: 23300019 DOI: 10.1158/1055-9965.EPI-12-0987] [Cited by in Crossref: 21] [Cited by in F6Publishing: 14] [Article Influence: 2.6] [Reference Citation Analysis]
136 DiNatale BC, Smith K, John K, Krishnegowda G, Amin SG, Perdew GH. Ah receptor antagonism represses head and neck tumor cell aggressive phenotype. Mol Cancer Res 2012;10:1369-79. [PMID: 22912337 DOI: 10.1158/1541-7786.MCR-12-0216] [Cited by in Crossref: 42] [Cited by in F6Publishing: 32] [Article Influence: 4.7] [Reference Citation Analysis]
137 Badoual C, Sandoval F, Pere H, Hans S, Gey A, Merillon N, Van Ryswick C, Quintin-Colonna F, Bruneval P, Brasnu D, Fridman WH, Tartour E. Better understanding tumor-host interaction in head and neck cancer to improve the design and development of immunotherapeutic strategies. Head Neck 2010;32:946-58. [PMID: 20191626 DOI: 10.1002/hed.21346] [Cited by in Crossref: 9] [Cited by in F6Publishing: 29] [Article Influence: 0.8] [Reference Citation Analysis]
138 Chang K, Kao H, Wu C, Fang K, Chang Y, Huang Y, Liu S, Cheng M. Pretreatment Interleukin-6 Serum Levels Are Associated with Patient Survival for Oral Cavity Squamous Cell Carcinoma. Otolaryngol Head Neck Surg 2013;148:786-91. [DOI: 10.1177/0194599813478573] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 2.4] [Reference Citation Analysis]
139 Sun R, Luo J, Li D, Shu Y, Luo C, Wang SS, Qin J, Zhang GM, Feng ZH. Neutrophils with protumor potential could efficiently suppress tumor growth after cytokine priming and in presence of normal NK cells. Oncotarget 2014;5:12621-34. [PMID: 25587026 DOI: 10.18632/oncotarget.2181] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 3.2] [Reference Citation Analysis]
140 Arthur AE, Peterson KE, Shen J, Djuric Z, Taylor JM, Hebert JR, Duffy SA, Peterson LA, Bellile EL, Whitfield JR, Chepeha DB, Schipper MJ, Wolf GT, Rozek LS. Diet and proinflammatory cytokine levels in head and neck squamous cell carcinoma. Cancer 2014;120:2704-12. [PMID: 24830761 DOI: 10.1002/cncr.28778] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 2.7] [Reference Citation Analysis]
141 Koch AT, Love-Homan L, Espinosa-Cotton M, Stanam A, Simons AL. MyD88-Dependent Signaling Decreases the Antitumor Efficacy of Epidermal Growth Factor Receptor Inhibition in Head and Neck Cancer Cells. Cancer Res 2015;75:1657-67. [PMID: 25712126 DOI: 10.1158/0008-5472.CAN-14-2061] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 2.2] [Reference Citation Analysis]
142 Sánchez-Rodríguez C, Cruces KP, Riestra Ayora J, Martín-Sanz E, Sanz-Fernández R. BCG immune activation reduces growth and angiogenesis in an in vitro model of head and neck squamous cell carcinoma. Vaccine 2017;35:6395-403. [PMID: 29029943 DOI: 10.1016/j.vaccine.2017.10.008] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
143 Aarstad HJ, Vintermyr OK, Ulvestad E, Aarstad HH, Kross KW, Heimdal JH. Peripheral blood monocyte and T-lymphocyte activation levels at diagnosis predict long-term survival in head and neck squamous cell carcinoma patients. APMIS 2015;123:305-14. [PMID: 25801083 DOI: 10.1111/apm.12356] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
144 Kim HS, Chen YC, Nör F, Warner KA, Andrews A, Wagner VP, Zhang Z, Zhang Z, Martins MD, Pearson AT, Yoon E, Nör JE. Endothelial-derived interleukin-6 induces cancer stem cell motility by generating a chemotactic gradient towards blood vessels. Oncotarget 2017;8:100339-52. [PMID: 29245982 DOI: 10.18632/oncotarget.22225] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
145 Thiel A, Kesselring R, Pries R, Puzik A, Wittkopf N, Wollenberg B. Expression of the T cell receptor αβ on a CD123+ BDCA2+ HLA-DR+ subpopulation in head and neck squamous cell carcinoma. PLoS One 2011;6:e15997. [PMID: 21264308 DOI: 10.1371/journal.pone.0015997] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
146 Solomon I, Voiculescu VM, Caruntu C, Lupu M, Popa A, Ilie MA, Albulescu R, Caruntu A, Tanase C, Constantin C, Neagu M, Boda D. Neuroendocrine Factors and Head and Neck Squamous Cell Carcinoma: An Affair to Remember. Dis Markers 2018;2018:9787831. [PMID: 29854027 DOI: 10.1155/2018/9787831] [Cited by in Crossref: 30] [Cited by in F6Publishing: 33] [Article Influence: 10.0] [Reference Citation Analysis]
147 Xu Q, Wang C, Yuan X, Feng Z, Han Z. Prognostic Value of Tumor-Infiltrating Lymphocytes for Patients With Head and Neck Squamous Cell Carcinoma. Transl Oncol 2017;10:10-6. [PMID: 27888708 DOI: 10.1016/j.tranon.2016.10.005] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 6.2] [Reference Citation Analysis]
148 Germano G, Mantovani A, Allavena P. Targeting of the innate immunity/inflammation as complementary anti-tumor therapies. Annals of Medicine 2011;43:581-93. [DOI: 10.3109/07853890.2011.595732] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 1.6] [Reference Citation Analysis]
149 Arduino PG, Menegatti E, Cappello N, Martina E, Gardino N, Tanteri C, Cavallo F, Scully C, Broccoletti R. Possible role for interleukins as biomarkers for mortality and recurrence in oral cancer. Int J Biol Markers 2015;30:e262-6. [PMID: 25838055 DOI: 10.5301/jbm.5000142] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 2.8] [Reference Citation Analysis]
150 Cottin SC, Turcotte S, Douville P, Meyer F, Bairati I. Predictors of circulating INTERLEUKIN-6 levels in head and neck cancer patients. Cancers Head Neck 2018;3:1. [PMID: 29951282 DOI: 10.1186/s41199-018-0029-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
151 Argiris A, Lee SC, Feinstein T, Thomas S, Branstetter BF 4th, Seethala R, Wang L, Gooding W, Grandis JR, Ferris RL. Serum biomarkers as potential predictors of antitumor activity of cetuximab-containing therapy for locally advanced head and neck cancer. Oral Oncol 2011;47:961-6. [PMID: 21889392 DOI: 10.1016/j.oraloncology.2011.07.034] [Cited by in Crossref: 36] [Cited by in F6Publishing: 31] [Article Influence: 3.6] [Reference Citation Analysis]
152 Tu HF, Liu CJ, Liu SY, Chen YP, Yu EH, Lin SC, Chang KW. Serum decoy receptor 3 level: a predictive marker for nodal metastasis and survival among oral cavity cancer patients. Head Neck 2011;33:396-402. [PMID: 20645287 DOI: 10.1002/hed.21467] [Cited by in Crossref: 3] [Cited by in F6Publishing: 8] [Article Influence: 0.3] [Reference Citation Analysis]
153 Osman TA, Costea DE, Johannessen AC. The use of salivary cytokines as a screening tool for oral squamous cell carcinoma : A review of the literature. J Oral Maxillofac Pathol 2012;16:256-61. [PMID: 22923900 DOI: 10.4103/0973-029X.99083] [Cited by in Crossref: 18] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
154 Leibowitz MS, Andrade Filho PA, Ferrone S, Ferris RL. Deficiency of activated STAT1 in head and neck cancer cells mediates TAP1-dependent escape from cytotoxic T lymphocytes. Cancer Immunol Immunother 2011;60:525-35. [PMID: 21207025 DOI: 10.1007/s00262-010-0961-7] [Cited by in Crossref: 64] [Cited by in F6Publishing: 60] [Article Influence: 6.4] [Reference Citation Analysis]
155 Tripathi SC, Matta A, Kaur J, Grigull J, Chauhan SS, Thakar A, Shukla NK, Duggal R, DattaGupta S, Ralhan R, Siu KW. Nuclear S100A7 is associated with poor prognosis in head and neck cancer. PLoS One 2010;5:e11939. [PMID: 20689826 DOI: 10.1371/journal.pone.0011939] [Cited by in Crossref: 40] [Cited by in F6Publishing: 39] [Article Influence: 3.6] [Reference Citation Analysis]
156 Taher MY, Davies DM, Maher J. The role of the interleukin (IL)-6/IL-6 receptor axis in cancer. Biochem Soc Trans 2018;46:1449-62. [PMID: 30467123 DOI: 10.1042/BST20180136] [Cited by in Crossref: 31] [Cited by in F6Publishing: 22] [Article Influence: 10.3] [Reference Citation Analysis]
157 Lippitz BE, Harris RA. Cytokine patterns in cancer patients: A review of the correlation between interleukin 6 and prognosis. Oncoimmunology. 2016;5:e1093722. [PMID: 27467926 DOI: 10.1080/2162402x.2015.1093722] [Cited by in Crossref: 87] [Cited by in F6Publishing: 62] [Article Influence: 17.4] [Reference Citation Analysis]
158 Panneer Selvam N, Sadaksharam J. Salivary interleukin-6 in the detection of oral cancer and precancer. Asia Pac J Clin Oncol 2015;11:236-41. [PMID: 25560781 DOI: 10.1111/ajco.12330] [Cited by in Crossref: 29] [Cited by in F6Publishing: 24] [Article Influence: 4.8] [Reference Citation Analysis]
159 Berggren KL, Restrepo Cruz S, Hixon MD, Cowan AT, Keysar SB, Craig S, James J, Barry M, Ozbun MA, Jimeno A, McCance DJ, Beswick EJ, Gan GN. MAPKAPK2 (MK2) inhibition mediates radiation-induced inflammatory cytokine production and tumor growth in head and neck squamous cell carcinoma. Oncogene 2019;38:7329-41. [PMID: 31417185 DOI: 10.1038/s41388-019-0945-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
160 Márton IJ, Horváth J, Lábiscsák P, Márkus B, Dezső B, Szabó A, Tar I, Piffkó J, Jakus P, Barabás J, Barabás P, Olasz L, Kövér Z, Tőzsér J, Sándor J, Csősz É, Scholtz B, Kiss C. Salivary IL-6 mRNA is a Robust Biomarker in Oral Squamous Cell Carcinoma. J Clin Med 2019;8:E1958. [PMID: 31766212 DOI: 10.3390/jcm8111958] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
161 Manca P, Raez LE, Salzberg M, Sanchez J, Hunis B, Rolfo C. The value of immunotherapy in head and neck cancer. Expert Opin Biol Ther 2019;19:35-43. [PMID: 30537444 DOI: 10.1080/14712598.2019.1556637] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
162 Arzmi MH, Dashper S, McCullough M. Polymicrobial interactions of Candida albicans and its role in oral carcinogenesis. J Oral Pathol Med 2019;48:546-51. [PMID: 31183906 DOI: 10.1111/jop.12905] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
163 Getz KR, Bellile E, Zarins KR, Rullman C, Chinn SB, Taylor JMG, Rozek LS, Wolf GT, Mondul AM. Statin use and head and neck squamous cell carcinoma outcomes. Int J Cancer 2020. [PMID: 33320960 DOI: 10.1002/ijc.33441] [Reference Citation Analysis]
164 Perri F, Ionna F, Longo F, Della Vittoria Scarpati G, De Angelis C, Ottaiano A, Botti G, Caponigro F. Immune Response Against Head and Neck Cancer: Biological Mechanisms and Implication on Therapy. Transl Oncol 2020;13:262-74. [PMID: 31869751 DOI: 10.1016/j.tranon.2019.11.008] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 6.5] [Reference Citation Analysis]
165 Li L, Deng L, Meng X, Gu C, Meng L, Li K, Zhang X, Meng Y, Xu W, Zhao L, Chen J, Zhu Z, Huang H. Tumor-targeting anti-EGFR x anti-PD1 bispecific antibody inhibits EGFR-overexpressing tumor growth by combining EGFR blockade and immune activation with direct tumor cell killing. Transl Oncol 2021;14:100916. [PMID: 33129108 DOI: 10.1016/j.tranon.2020.100916] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
166 Albesiano E, Davis M, See AP, Han JE, Lim M, Pardoll DM, Kim Y. Immunologic consequences of signal transducers and activators of transcription 3 activation in human squamous cell carcinoma. Cancer Res 2010;70:6467-76. [PMID: 20682796 DOI: 10.1158/0008-5472.CAN-09-4058] [Cited by in Crossref: 19] [Cited by in F6Publishing: 12] [Article Influence: 1.7] [Reference Citation Analysis]
167 Méry B, Guy JB, Espenel S, Wozny AS, Simonet S, Vallard A, Alphonse G, Ardail D, Rodriguez-Lafrasse C, Magné N. Targeting head and neck tumoral stem cells: From biological aspects to therapeutic perspectives. World J Stem Cells. 2016;8:13-21. [PMID: 26839637 DOI: 10.4252/wjsc.v8.i1.13] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 3.4] [Reference Citation Analysis]
168 Steinbichler TB, Savic D, Dejaco D, Romani A, Kofler B, Skvortsova II, Riechelmann H, Dudas J. Pleiotropic Effects of Epithelial Mesenchymal Crosstalk on Head and Neck Cancer: EMT and beyond. Cancer Microenviron 2019;12:67-76. [PMID: 31297730 DOI: 10.1007/s12307-019-00228-y] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
169 Ferris RL. Immunology and Immunotherapy of Head and Neck Cancer. J Clin Oncol 2015;33:3293-304. [PMID: 26351330 DOI: 10.1200/JCO.2015.61.1509] [Cited by in Crossref: 319] [Cited by in F6Publishing: 174] [Article Influence: 53.2] [Reference Citation Analysis]
170 Candau-alvarez A, Gil-campos M, De la Torre-aguilar MJ, Llorente-cantarero F, Lopez-miranda J, Perez-navero JL. Early Modification in Drainage of Interleukin-1β and Tumor Necrosis Factor-α Best Predicts Surgical-Site Infection After Cervical Neck Dissection for Oral Cancer. Journal of Oral and Maxillofacial Surgery 2015;73:1189-98. [DOI: 10.1016/j.joms.2014.12.023] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
171 Kayamori K, Sakamoto K, Nakashima T, Takayanagi H, Morita K, Omura K, Nguyen ST, Miki Y, Iimura T, Himeno A, Akashi T, Yamada-Okabe H, Ogata E, Yamaguchi A. Roles of interleukin-6 and parathyroid hormone-related peptide in osteoclast formation associated with oral cancers: significance of interleukin-6 synthesized by stromal cells in response to cancer cells. Am J Pathol 2010;176:968-80. [PMID: 20035059 DOI: 10.2353/ajpath.2010.090299] [Cited by in Crossref: 47] [Cited by in F6Publishing: 42] [Article Influence: 3.9] [Reference Citation Analysis]
172 Moody L, Crowder SL, Fruge AD, Locher JL, Demark-Wahnefried W, Rogers LQ, Delk-Licata A, Carroll WR, Spencer SA, Black M, Erdman JW Jr, Chen H, Pan YX, Arthur AE. Epigenetic stratification of head and neck cancer survivors reveals differences in lycopene levels, alcohol consumption, and methylation of immune regulatory genes. Clin Epigenetics 2020;12:138. [PMID: 32917280 DOI: 10.1186/s13148-020-00930-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
173 Dudás J, Fullár A, Bitsche M, Schartinger V, Kovalszky I, Sprinzl GM, Riechelmann H. Tumor-produced, active interleukin-1β regulates gene expression in carcinoma-associated fibroblasts. Exp Cell Res 2011;317:2222-9. [PMID: 21664353 DOI: 10.1016/j.yexcr.2011.05.023] [Cited by in Crossref: 45] [Cited by in F6Publishing: 39] [Article Influence: 4.5] [Reference Citation Analysis]
174 Astradsson T, Sellberg F, Berglund D, Ehrsson YT, Laurell GFE. Systemic Inflammatory Reaction in Patients With Head and Neck Cancer-An Explorative Study. Front Oncol 2019;9:1177. [PMID: 31750257 DOI: 10.3389/fonc.2019.01177] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
175 Whiteley W, Jackson C, Lewis S, Lowe G, Rumley A, Sandercock P, Wardlaw J, Dennis M, Sudlow C. Inflammatory markers and poor outcome after stroke: a prospective cohort study and systematic review of interleukin-6. PLoS Med 2009;6:e1000145. [PMID: 19901973 DOI: 10.1371/journal.pmed.1000145] [Cited by in Crossref: 163] [Cited by in F6Publishing: 147] [Article Influence: 13.6] [Reference Citation Analysis]
176 Idris A, Ghazali NB, Koh D. Interleukin 1β-A Potential Salivary Biomarker for Cancer Progression? Biomark Cancer 2015;7:25-9. [PMID: 26244033 DOI: 10.4137/BIC.S25375] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
177 Dineshkumar T, Ashwini BK, Rameshkumar A, Rajashree P, Ramya R, Rajkumar K. Salivary and Serum Interleukin-6 Levels in Oral Premalignant Disorders and Squamous Cell Carcinoma: Diagnostic Value and Clinicopathologic Correlations. Asian Pac J Cancer Prev 2016;17:4899-906. [PMID: 28032493 DOI: 10.22034/APJCP.2016.17.11.4899] [Cited by in F6Publishing: 9] [Reference Citation Analysis]
178 Jian SL, Hsieh HY, Liao CT, Yen TC, Nien SW, Cheng AJ, Juang JL. Gα₁₂ drives invasion of oral squamous cell carcinoma through up-regulation of proinflammatory cytokines. PLoS One 2013;8:e66133. [PMID: 23762476 DOI: 10.1371/journal.pone.0066133] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
179 Stabile LP, Egloff AM, Gibson MK, Gooding WE, Ohr J, Zhou P, Rothenberger NJ, Wang L, Geiger JL, Flaherty JT, Grandis JR, Bauman JE. IL6 is associated with response to dasatinib and cetuximab: Phase II clinical trial with mechanistic correlatives in cetuximab-resistant head and neck cancer. Oral Oncol 2017;69:38-45. [PMID: 28559019 DOI: 10.1016/j.oraloncology.2017.03.011] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 4.3] [Reference Citation Analysis]
180 Su YW, Xie TX, Sano D, Myers JN. IL-6 stabilizes Twist and enhances tumor cell motility in head and neck cancer cells through activation of casein kinase 2. PLoS One 2011;6:e19412. [PMID: 21559372 DOI: 10.1371/journal.pone.0019412] [Cited by in Crossref: 48] [Cited by in F6Publishing: 45] [Article Influence: 4.8] [Reference Citation Analysis]
181 Tse GM, King AD, Yu AMC, Lam CCF, Chan AWH, Chen GG, Yeung DK, Yu K, Bhatia KS, Chan ABW. Correlation of biomarkers in head and neck squamous cell carcinoma. Otolaryngol Head Neck Surg 2010;143:795-800. [DOI: 10.1016/j.otohns.2010.08.028] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
182 Komatsu N, Matsueda S, Tashiro K, Ioji T, Shichijo S, Noguchi M, Yamada A, Doi A, Suekane S, Moriya F, Matsuoka K, Kuhara S, Itoh K, Sasada T. Gene expression profiles in peripheral blood as a biomarker in cancer patients receiving peptide vaccination. Cancer 2012;118:3208-21. [PMID: 22071976 DOI: 10.1002/cncr.26636] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 2.5] [Reference Citation Analysis]
183 Ralhan R. How will increasing our knowledge of the head and neck cancer cells' secretome benefit head and neck squamous cell carcinoma patients? Expert Rev Proteomics 2012;9:115-8. [PMID: 22462781 DOI: 10.1586/epr.12.1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
184 Aarstad HJ, Aarstad HH, Vintermyr OK, Kross KW, Lybak S, Heimdal JH. In vitro Monocyte IL-6 Secretion Levels Following Stimulation with Autologous Spheroids Derived from Tumour or Benign Mucosa Predict Long-term Survival in Head and Neck Squamous Cell Carcinoma Patients. Scand J Immunol 2017;85:211-9. [PMID: 27943380 DOI: 10.1111/sji.12518] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
185 Al-Asmari AK, Riyasdeen A, Islam M. Scorpion Venom Causes Upregulation of p53 and Downregulation of Bcl-xL and BID Protein Expression by Modulating Signaling Proteins Erk1/2 and STAT3, and DNA Damage in Breast and Colorectal Cancer Cell Lines. Integr Cancer Ther 2018;17:271-81. [PMID: 28438053 DOI: 10.1177/1534735417704949] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
186 Lee KM, Han S, Park WY, Kang D. Identification and application of biomarkers in molecular and genomic epidemiologic research. J Prev Med Public Health 2009;42:349-55. [PMID: 20009480 DOI: 10.3961/jpmph.2009.42.6.349] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
187 Shishido SN, Varahan S, Yuan K, Li X, Fleming SD. Humoral innate immune response and disease. Clin Immunol 2012;144:142-58. [PMID: 22771788 DOI: 10.1016/j.clim.2012.06.002] [Cited by in Crossref: 46] [Cited by in F6Publishing: 39] [Article Influence: 5.1] [Reference Citation Analysis]
188 Chen C, Chu C, Liu K, Huang CF, Chang J, Pan W, Chen H, Cheng Y, Lee K, Chen M, Kuo C, Chen L. Gene expression profiling for analysis acquired oxaliplatin resistant factors in human gastric carcinoma TSGH-S3 cells: The role of IL-6 signaling and Nrf2/AKR1C axis identification. Biochemical Pharmacology 2013;86:872-87. [DOI: 10.1016/j.bcp.2013.07.025] [Cited by in Crossref: 28] [Cited by in F6Publishing: 24] [Article Influence: 3.5] [Reference Citation Analysis]
189 Diez-Fraile A, Ceulaer J, Derpoorter C, Spaas C, Backer T, Lamoral P, Abeloos J, Lammens T. Circulating Non-Coding RNAs in Head and Neck Cancer: Roles in Diagnosis, Prognosis, and Therapy Monitoring. Cells 2020;10:E48. [PMID: 33396240 DOI: 10.3390/cells10010048] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]